Evotec (EVTCY) News Today $4.78 +0.11 (+2.36%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Halozyme withdraws $2.1 billion buyout offer for German drug developer EvotecNovember 25, 2024 | finance.yahoo.comEQS-News: Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market ConditionsNovember 6, 2024 | markets.businessinsider.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - What's Next?Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low - Here's WhyOctober 30, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 52-Week Low - Here's WhyEvotec (OTCMKTS:EVTCY) Sets New 12-Month Low - Here's WhyOctober 21, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Hits New 12-Month Low - Here's What HappenedEvotec (OTCMKTS:EVTCY) Hits New 1-Year Low - Time to Sell?October 14, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Sets New 1-Year Low - Time to Sell?Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low - What's Next?October 8, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Share Price Crosses Below 50 Day Moving Average of $3.70Evotec (OTCMKTS:EVTCY) Shares Cross Below 50 Day Moving Average of $3.70October 1, 2024 | marketbeat.comEvotec SE: Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD Toulouse, FranceSeptember 20, 2024 | finanznachrichten.deEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.27Evotec (OTCMKTS:EVTCY) Sets New 1-Year Low at $3.27September 11, 2024 | marketbeat.comEvotec (OTCMKTS:EVTCY) Reaches New 12-Month Low at $3.66Evotec (OTCMKTS:EVTCY) Sets New 52-Week Low at $3.66August 30, 2024 | marketbeat.comAnalysts Have Been Trimming Their Evotec SE (ETR:EVT) Price Target After Its Latest ReportAugust 17, 2024 | uk.finance.yahoo.comEvotec SE (NASDAQ:EVO) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comEvotec SE: Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers SquibbAugust 8, 2024 | finanznachrichten.deEQEvotec SE Appoints Dr Christian Wojczewski as Chief Executive OfficerApril 24, 2024 | finance.yahoo.comEQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive OfficerApril 23, 2024 | markets.businessinsider.comEvotec SE: Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The ClinicMarch 6, 2024 | finanznachrichten.deEvotec SE: Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD TherapiesJanuary 10, 2024 | finanznachrichten.deEvotec, Owkin Anounce A.I.-Powered Collaboration In Oncology, Immunology, And InflammationJanuary 4, 2024 | markets.businessinsider.comEvotec SE (NASDAQ:EVO) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comEQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate updateNovember 8, 2023 | markets.businessinsider.com65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in SingaporeOctober 5, 2023 | finance.yahoo.comEvotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D EconomySeptember 27, 2023 | finance.yahoo.comEvotec SE (EVO) Stock Historical Prices & Data - Yahoo FinanceSeptember 21, 2023 | finance.yahoo.comIs There Now An Opportunity In Evotec SE (ETR:EVT)?May 30, 2023 | finance.yahoo.comEvotec SE (ETR:EVT) Shares Could Be 37% Below Their Intrinsic Value EstimateMay 14, 2023 | finance.yahoo.comEvotec SE: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023May 13, 2023 | finanznachrichten.deEvotec SE ADR (EVO) Earnings Dates & ReportsMay 12, 2023 | investing.comEvotec SE ADR (EVO)May 10, 2023 | investing.comEvotec SE: Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial ManufacturingMay 9, 2023 | finanznachrichten.deEvotec SE Provides Update on Cyber AttackApril 10, 2023 | finance.yahoo.comEvotec SE: Evotec Receives € 150 m Loan from European Investment BankFebruary 10, 2023 | finanznachrichten.deEQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionJanuary 31, 2023 | markets.businessinsider.comWith 47% ownership, Evotec SE (ETR:EVT) has piqued the interest of institutional investorsDecember 22, 2022 | ca.finance.yahoo.comEvotec SE: Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers SquibbDecember 17, 2022 | finanznachrichten.deEvotec SE: Just - Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies ProgramSeptember 21, 2022 | finanznachrichten.deEvotec: US Unit Gets $49.9 Mln Antibodies Contract From U.S. Department Of DefenseSeptember 20, 2022 | markets.businessinsider.comEvotec SE: Evotec Initiates Ground-Breaking for New Biologics Facility J.POD Toulouse, FranceSeptember 17, 2022 | finanznachrichten.deEvotec SE's (EVOTF) CEO Dr. Werner Lanthaler on Q2 2022 Results - Earnings Call TranscriptAugust 13, 2022 | seekingalpha.comEvotec Slips To Loss In Q3, Revenues Rise; Lifts FY22 Revenue View, Backs Adj. EBITDA ForecastAugust 11, 2022 | nasdaq.comDGAP-News: Evotec SE reports results for the first half-year 2022 and provides corporate updatesAugust 11, 2022 | markets.businessinsider.comEvotec SE Reports Results for the First Half-year 2022 and Provides Corporate UpdatesAugust 11, 2022 | finance.yahoo.comEvotec SE: Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303August 10, 2022 | finanznachrichten.deEvotec Q1 Adj. EBITDA Down, Revenues UpMay 11, 2022 | nasdaq.comEvotec SE Fiscal Year 2021 Results: ‘Setting the Pace’ on the Data-Driven R&D Autobahn to CuresApril 12, 2022 | apnews.comEvotec AG: Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to CuresApril 12, 2022 | finanznachrichten.deEvotec SE reports FY resultsApril 12, 2022 | seekingalpha.comEvotec FY21 Net Income Surges, Operating Result Down; Sees Higher Group Revenues In FY22April 12, 2022 | nasdaq.comEvotec Confirms Goals Of Action Plan 2025March 2, 2022 | markets.businessinsider.comEvotec, UoB To Expand Molecular Patient Database In Kidney Diseases With Nephrotic SyndromeMarch 1, 2022 | markets.businessinsider.comEvotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assetsFebruary 4, 2022 | uk.finance.yahoo.com Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. EVTCY Media Mentions By Week EVTCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVTCY News Sentiment▼0.000.59▲Average Medical News Sentiment EVTCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVTCY Articles This Week▼00▲EVTCY Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CYTK News Today BPMC News Today VKTX News Today BBIO News Today ZLDPF News Today KRYS News Today CRNX News Today TGTX News Today RARE News Today ADMA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EVTCY) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Evotec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVTCY Stock Alerts